BRAF mutations are frequently detected in melanoma and were identified in arrays of cancers including colorectal cancer, non–small cell lung carcinoma, non–Hodgkin lymphoma, hairy cell leukemia, and thyroid cancer [14–17]. This evidence concerns the gene BRAF and thyroid cancer.